J. A. Liu, S. Chaulagain, X. Xie, P. S. Creisher, W. Zhong, T. Zhang, M. Taddese, K. Shi, H.-S. Park, H. Hcnir, A. P. Arnold, R. S. Baric, N. B. Barahona, E. B. Engler-Chiurazzi, K. J. Zwezdaryk, C. L. Thio, A. Balagopal, J. R. Harkema, E. A. Thompson, A. Pekosz, A. L. Cox, S. L. Klein
Males are more likely to suffer severe outcomes during acute COVID-19 and a greater proportion of females develop post-acute sequalae of COVID-19 (PASC). To identify mechanisms of PASC, mice were infected with SARS-CoV-2 and viral, inflammatory, and neurocognitive outcomes were evaluated through 84 days post-infection. Sex differences were not observed in virus replication or persistence of viral RNA in pulmonary or extrapulmonary tissues. After infectious virus clearance, females exhibited persistent neurocognitive impairments, and greater frequencies of inflammatory myeloid cells, neuroinflammation, and dysregulated T cells, including effector memory and Tregs. Sex differences in persistent inflammation and cognitive impairments during PASC were mediated by the presence of two X chromosomes and infection-induced upregulation of the X-linked genes Xist and Tlr7, which was reversed by pharmacological inhibition of TLR7 activity during the PASC phase. Sustained X-linked TLR7-mediated inflammation underlies how the burden of PASC is greater for females and provides a therapeutic target.